Novo Nordisk A/S Class B (NOVO B)
NOVO B · Health Care · 
Denmark
Novo Nordisk A/S Class B (NOVO B) is a Danish company in the Health Care sector. The stock has its largest weight in SPFS (MSCI World Health Care), at 1.38%. Anyone who holds an ETF containing Novo Nordisk A/S also has an indirect stake in the company.
Data and Charts: Novo Nordisk A/S
Key Data for Novo Nordisk A/S
Alysly Data Analysis: Novo Nordisk A/S
Novo Nordisk A/S Connections
The map shows how Novo Nordisk A/S connects to ETFs, indices and other names. Each link is based on measured data and is not a recommendation.
- Denmark Country · domicile
- XDWH ETF · holds
- SPFS ETF · holds
- Health Care Sector · sector
- Glaxosmithkline Stock · similar ETF exposure
- Straumann Holding Stock · similar ETF exposure
- Smith and Nephew Stock · similar ETF exposure
What ETF Is Novo Nordisk A/S In?
Novo Nordisk A/S has very high ETF coverage and is held by 25 of the 104 ETFs we track, which together follow 10 indices. That puts the stock in more ETFs than 92.5% of the 4,341 stocks we track.
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| SPFS | MSCI World Health Care | 1.38% | €13.82 |
| XDWH | MSCI World Health Care | 1.38% | €13.80 |
| SPYE | MSCI Europe | 0.91% | €9.11 |
| XMEU / XIEE | MSCI Europe | 0.91% | €9.09 |
| IMEA | MSCI Europe | 0.90% | €9.00 |
| X600 / XESU | STOXX Europe 600 | 0.83% | €8.31 |
| EXSA | STOXX Europe 600 | 0.83% | €8.30 |
| XSX6 / XSX7 | STOXX Europe 600 | 0.83% | €8.27 |
| WVAL | MSCI World Value | 0.52% | €5.16 |
| EXUS / EXU1 | MSCI World ex USA | 0.51% | €5.10 |
| XDEQ | MSCI World Quality | 0.42% | €4.18 |
| EUNL | MSCI World | 0.14% | €1.40 |
| XDWD / XDWL | MSCI World | 0.14% | €1.37 |
| SWWD | MSCI World | 0.13% | €1.35 |
| SPPW | MSCI World | 0.13% | €1.35 |
| SPYY | MSCI ACWI | 0.12% | €1.24 |
| WIMI | MSCI World IMI | 0.12% | €1.23 |
| IUSQ | MSCI ACWI | 0.12% | €1.20 |
| SPYI / SPSA | MSCI ACWI IMI | 0.11% | €1.11 |
The last column shows how much of €1,000 in one of these funds goes to Novo Nordisk A/S, based on each fund's latest holdings list.
US-listed ETFs holding Novo Nordisk A/S (weight per latest SEC filing): VXUS 0.34%. These funds are registered in the US; retail investors in the EU usually cannot buy them.
Novo Nordisk A/S Weight in iShares Core MSCI World (EUNL) Since 2019
In iShares Core MSCI World (EUNL), Novo Nordisk A/S had a weight of 0.23% on Sep 30, 2019 and 0.14% on Oct 29, 2026. The fund tracks the MSCI World. Its share peaked at 0.71% on Jun 28, 2024. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.
What's Inside Your ETF Portfolio and the ETF overlap check show how much Novo Nordisk A/S overlaps with the rest of a portfolio.
Stocks With ETF Exposure Similar to Novo Nordisk A/S
| Stock | Shared ETFs | r |
|---|---|---|
| Novo Nordisk A/S | – | – |
 Glaxosmithkline | 25 | – |
 Astrazeneca | 24 | – |
| Straumann Holding | 24 | – |
| Smith and Nephew | 24 | – |
| Demant A/S | 23 | – |
 Haleon | 23 | – |
| Novartis | 25 | – |
| Coloplast A/S | 23 | – |
These stocks reach a portfolio through largely the same funds as Novo Nordisk A/S. “Shared ETFs” counts the funds that hold both.
